当前位置:
X-MOL 学术
›
Cell. Mol. Immunol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Blocking PD-L1 for anti-liver cancer immunity: USP22 represents a critical cotarget.
Cellular & Molecular Immunology ( IF 24.1 ) Pub Date : 2019-12-19 , DOI: 10.1038/s41423-019-0348-4 Xing Huang 1, 2, 3 , Xiaozhen Zhang 1, 2, 3 , Xueli Bai 1, 2, 3 , Tingbo Liang 1, 2, 3
中文翻译:
阻断PD-L1的抗肝癌免疫性:USP22代表着至关重要的共同靶标。
更新日期:2019-12-19
Cellular & Molecular Immunology ( IF 24.1 ) Pub Date : 2019-12-19 , DOI: 10.1038/s41423-019-0348-4 Xing Huang 1, 2, 3 , Xiaozhen Zhang 1, 2, 3 , Xueli Bai 1, 2, 3 , Tingbo Liang 1, 2, 3
Affiliation
中文翻译:
阻断PD-L1的抗肝癌免疫性:USP22代表着至关重要的共同靶标。